...
机译:堵塞单克隆抗体方案作为避免抗CD38干扰免疫检测的替代策略
Univ Sao Paulo Sch Med FMUSP Discipline Hematol Transfus &
Cell Therapy Sao Paulo Brazil;
Univ Sao Paulo Sch Med FMUSP Discipline Hematol Transfus &
Cell Therapy Sao Paulo Brazil;
Univ Sao Paulo Sch Med FMUSP Discipline Hematol Transfus &
Cell Therapy Sao Paulo Brazil;
Fundacao Prosangue Hemoctr Sao Paulo Sao Paulo Brazil;
Fundacao Hemominas Belo Horizonte MG Brazil;
HEMOCE Hematol &
Hemotherapy Ctr Fortaleza Ceara Brazil;
Univ Sao Paulo Sch Med FMUSP Discipline Hematol Transfus &
Cell Therapy Sao Paulo Brazil;
Fundacao Hemominas Belo Horizonte MG Brazil;
HEMOCE Hematol &
Hemotherapy Ctr Fortaleza Ceara Brazil;
Univ Sao Paulo Sch Med FMUSP Discipline Hematol Transfus &
Cell Therapy Sao Paulo Brazil;
Fundacao Prosangue Hemoctr Sao Paulo Sao Paulo Brazil;
Univ Sao Paulo Sch Med FMUSP Discipline Hematol Transfus &
Cell Therapy Sao Paulo Brazil;
机译:堵塞单克隆抗体方案作为避免抗CD38干扰免疫检测的替代策略
机译:案例研究:干扰抗CD38人源化单克隆抗体(Isatuximab)引起的相容性测试
机译:单克隆抗CD38和抗CD47治疗干扰血小板抗体筛网试验方法
机译:集成单克隆抗体生产工艺替代品的设计与评估:连续制造的机会
机译:单克隆抗体的制备,鉴定和功效测试
机译:克服抗CD38单克隆抗体在相容性测试中产生的干扰的新方法
机译:用于接受抗CD38单克隆抗体达拉汀治疗多发性骨髓瘤的患者患者预输血免疫角膜学检测的考虑